API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com//news-release/2024/01/18/2811519/37414/en/Panbela-Announces-Publication-of-Clinical-Data-Titled-Phase-1-study-of-high-dose-DFMO-celecoxib-cyclophosphamide-and-topotecan-for-patients-with-relapsed-neuroblastoma-A-New-Approa.html
https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables
https://www.prnewswire.com/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-initiation-of-confirmatory-phase-3-clinical-trial-of-zepzelca-lurbinectedin-for-the-treatment-of-patients-with-relapsed-small-cell-lung-cancer-301442832.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-14-2021-1626258357.pdf
https://www.pharmacompass.com/pdf/news/teva-initiates-voluntary-nationwide-recall-of-one-lot-of-topotecan-injection-4-mg4-ml-1625226936.pdf
https://www.globenewswire.com/news-release/2020/06/01/2041365/0/en/Aileron-Therapeutics-Announces-Positive-Interim-Results-from-Phase-1b-2-Clinical-Trial-of-ALRN-6924-for-the-Prevention-of-Topotecan-induced-Toxicities-During-Treatment-for-Small-Ce.html
http://www.pharmafile.com/news/527670/abbvie-shuts-down-rova-t-development-first-line-advanced-small-cell-lung-cancer-followin
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206074
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204406
http://www.pharmatimes.com/news/us_expands_scope_of_avastin_in_ovarian_cancer_1180321
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206962
http://www.fiercebiotech.com/biotech/pharmamar-pits-small-cell-lung-cancer-hopeful-against-competition-phiii-trial
http://www.pharmatimes.com/Article/15-11-25/NICE_ovarian_cancer_guideline_recommends_two_drugs_but_rejects_three.aspx
http://www.forbes.com/sites/elaineschattner/2015/08/05/why-evidence-from-a-clinical-trial-of-intraperitoneal-treatment-in-ovarian-cancer-has-limited-value/
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52537a-eng.php
http://www.fiercepharma.com/story/gsk-deals-done-now-novartis-has-deliver-cancer-growth-pledge/2015-03-02
http://www.roche.com/media/store/releases/med-cor-2015-02-27.htm
http://www.pharmamar.com/pharmamar-start-phase-iii-pm1183-doxorubicin-relapsed-sclc.aspx
http://www.pharmatimes.com/Article/14-12-23/NICE_reviews_five_ovarian_cancer_drugs.aspx